Peli BioThermal has acquired Evo from BioLife Solutions, enhancing its product and service offerings in temperature-controlled logistics, particularly for the pharmaceutical sector. This acquisition allows Peli BioThermal to provide comprehensive cold chain solutions, especially in the growing Cell and Gene Therapy market. CEO Sam Herbert highlighted the strategic importance of this move, which integrates Evo’s cryogenic shippers and technology with Peli BioThermal’s existing products. The acquisition aims to improve customer service and operational flexibility, while also reinforcing Peli BioThermal’s market position and growth potential.

Source: https://www.stattimes.com/latest-news/peli-biothermal-acquires-evo-to-expand-cold-chain-solutions-1356742